Quince Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +96.6% | -5.1% | -15.4% | -6.2% | -9.5% | -6.5% | +9.5% | -6.2% | -14.9% | -71.5% | +365.7% | |
| – | -9.1% | -9.0% | -9.9% | -18.5% | -14.9% | -23.2% | +10.4% | -21.8% | -21.6% | +11.7% | +382.5% | |
| – | -4.1% | +5.1% | -63.8% | -66.1% | +132.2% | +25.1% | +116.5% | -61.7% | -10.0% | +212.7% | +538.6% | |
| – | – | – | -12.4% | -19.5% | -14.8% | -22.5% | +9.8% | -24.3% | – | – | +538.6% | |
| – | – | – | -0.7% | +3.2% | -11.4% | +3.9% | +8.3% | – | – | – | -9.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -2.2% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | -2.2% | -0.7% | +4.4% | -6.9% | +3.9% | +8.3% | +0.2% | +0.1% | +0.0% | – | |
| – | +3,575.8% | +2.8% | +3.2% | -7.1% | +3.4% | +5.0% | +19.2% | +3.2% | +18.7% | -91.5% | +41.6% | |
| – | +324.9% | +2.8% | +4.9% | -47.4% | +34.2% | +14.8% | -10.6% | +248.8% | +66.0% | -79.7% | -3.1% | |
| – | – | – | +1.1% | +7.4% | -5.0% | +6.3% | +9.8% | +15,644.6% | – | – | – | |
| – | +397.1% | +1.8% | +16.2% | -32.6% | +79.0% | +3.6% | -41.5% | +93.5% | -34.7% | +142.6% | -14.0% | |
| – | – | +0.7% | +2.3% | +7.7% | -3.9% | +6.6% | +11.3% | – | – | – | – | |
| – | +2.3% | -12.8% | -36.7% | -4.3% | -32.9% | -38.4% | -36.8% | -91.0% | -3,472.4% | – | +592.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23,725.7% | -99.5% | +0.2% | +0.2% | +0.2% | +1.6% | +6.2% | +15.6% | +3.3% | -10.1% | +2,348.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.